Erratum: Strategy for reversing resistance to a single anticancer agent in human prostate and pancreatic carcinomas (Proc. Natl. Acad. Sci. U.S.A. (2007) 104 (3484–3489) DOI: 10.1073/pnas.0700042104);Strategy for reversing resistance to a single anticancer agent in human prostate and pancreatic carcinomas

Proceedings of the National Academy of Sciences of the United States of America

Volumn 104, Issue 9, 2007, Pages 3484-3489

  Lebedeva, Irina V ^a   Washington, Ilyas ^b   Sarkar, Devanand ^a   Clark, Jennifer A ^b   Fine, Robert L ^a   Dent, Paul ^c   Curiel, David T ^d   Turro, Nicholas J ^b   Fisher, Paul B ^a  

^a Columbia University ^*  (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^d University of Alabama at Birmingham   (United States)

Author keywords

BCL xL; Cancer selective apoptosis; Endoperoxide; mda 7 IL 24; Reactive oxygen species

Indexed keywords

ACETYLCYSTEINE; ANTINEOPLASTIC AGENT; ANTIOXIDANT; CYTOKINE; ENDOPEROXIDE; GENE PRODUCT; INHIBITOR OF APOPTOSIS PROTEIN; INTERLEUKIN 24; MELANOMA DIFFERENTIATION INDUCED GENE 7; PROTEIN BCL XL; REACTIVE OXYGEN METABOLITE; SINGLET OXYGEN; TIRON; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER RESISTANCE; CONTROLLED STUDY; DRUG EFFICACY; GENE; HUMAN; HUMAN CELL; IN VITRO STUDY; MDA 7 GENE; METASTASIS; PANCREAS CARCINOMA; PRIORITY JOURNAL; PROSTATE CARCINOMA;

EID: 33847622928     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.2204209119     Document Type: Erratum

References (41)

1. Jiang H, Lin JJ, Su ZZ, Goldstein NI, Fisher PB (1995) Oncogene 11:2477-2486.
2. Fisher PB (2005) Cancer Res 65:10128-10138.
3. Fisher PB, Gopalkrishnan RV, Chada S, Ramesh R, Grimm EA, Rosenfeld MR, Curiel DT, Dent P (2003) Cancer Biol Ther 2:S23-S37.
4. Gupta P, Su ZZ, Lebedeva IV, Sarkar D, Sauane M, Emdad L, Bachelor MA, Grant S, Curiel DT, Dent P, et al. (2006) Pharmacol Ther 111:596-628.
5. Lebedeva IV, Sauane M, Gopalkrishnan RV, Sarkar D, Su ZZ, Gupta P, Nemunaitis J, Cunningham C, Yacoub A, Dent P, et al. (2005) Mol Ther 11:4-18.
6. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ (2007) CA Cancer J Clin 57:43-66.
7. Simoneau AR (2006) Rev Urol 2(Suppl 8):S56-S67.
8. Bardeesy N, DePinho RA (2002) Nat Rev Cancer 2:897-909.
9. Lebedeva IV, Sarkar D, Su ZZ, Gopalkrishnan RV, Athar M, Randolph A, Valerie K, Dent P, Fisher PB (2006) Cancer Res 66:2403-2413.
10. Lebedeva IV, Su ZZ, Sarkar D, Gopalkrishnan RV, Waxman S, Yacoub A, Dent P, Fisher PB (2005) Oncogene 24:585-596.
11. Su Z, Lebedeva IV, Gopalkrishnan RV, Goldstein NI, Stein CA, Reed JC, Dent P, Fisher PB (2001) Proc Natl Acad Sci USA 98:10332-10337.
12. Thannickal VJ, Fanburg BL (2000) Am J Physiol 279:L1005-L1028.
13. Cejas P, Casado E, Belda-Iniesta C, De Castro J, Espinosa E, Redondo A, Sereno M, Garcia-Cabezas MA, Vara JA, Dominguez-Caceres A, et al. (2004) Cancer Causes Control 15:707-719.
14. Mates JM, Sanchez-Jimenez FM (2000) Int J Biochem Cell Biol 32:157-170.
15. Pelicano H, Carney D, Huang P (2004) Drug Resist Updat 7:97-110.
16. Dolmans DE, Fukumura D, Jain RK (2003) Nat Rev Cancer 3:380-387.
17. Hileman EO, Liu J, Albitar M, Keating MJ, Huang P (2004) Cancer Chemother Pharmacol 53:209-219.
18. Fang J, Sawa T, Akaike T, Akuta T, Sahoo SK, Khaled G, Hamada A, Maeda H (2003) Cancer Res 63:3567-3574.
19. Fennell DA, Corbo M, Pallaska A, Cotter FE (2001) Br J Cancer 84:1397-1404.
20. Kochevar IE, Lynch MC, Zhuang S, Lambert CR (2000) Photochem Photobiol 72:548-553.
21. Godar DE (2000) Methods Enzymol 319:309-330.
22. Schweitzer C, Schmidt R (2003) Chem Rev 103:1685-1757.
23. Cavalcante AK, Martinez GR, Di Mascio P, Menck CF, Agnez-Lima LF (2002) DNA Repair (Amst) 1:1051-1056.
24. Pellieux C, Dewilde A, Pierlot C, Aubry JM (2000) Methods Enzymol 319:197-207.
25. Dewilde A, Pellieux C, Hajjam S, Wattre P, Pierlot C, Hober D, Aubry JM (1996) J Photochem Photobiol B 36:23-29.
26. Lebedeva IV, Su ZZ, Sarkar D, Kitada S, Dent P, Waxman S, Reed JC, Fisher PB (2003) Cancer Res 63:8138-8144.
27. Lebedeva IV, Sarkar D, Su ZZ, Kitada S, Dent P, Stein CA, Reed JC, Fisher PB (2003) Oncogene 22:8758-8773.
28. Su ZZ, Lebedeva IV, Sarkar D, Emdad L, Gupta P, Kitada S, Dent P, Reed JC, Fisher PB (2006) Oncogene 25:2339-2348.
29. Amundson SA, Myers TG, Scudiero D, Kitada S, Reed JC, Fornace AJ, Jr (2000) Cancer Res 60:6101-6110.
30. Matsuzawa A, Ichijo H (2005) Antioxid Redox Signal 7:472-481.
31. Yang Y, Yu X (2003) FASEB J 17:790-799.
32. Li D, Ueta E, Kimura T, Yamamoto T, Osaki T (2004) Cancer Sci 95:644-650.
33. Sarkar D, Su ZZ, Vozhilla N, Park ES, Gupta P, Fisher PB (2005) Proc Natl Acad Sci USA 102:14034-14039.
34. Noureddini SC, Curiel DT (2005) Mol Pharm 2:341-347.
35. Hedley SJ, Chen J, Mountz JD, Li J, Curiel DT, Korokhov N, Kovesdi I (2006) Cancer Immunol Immunother 55:1412-1419.
36. Urasaki Y, Laco GS, Pourquier P, Takebayashi Y, Kohlhagen G, Gioffre C, Zhang H, Chatterjee D, Pantazis P, Pommier Y (2001) Cancer Res 61:1964-1969.
37. Dinnen RD, Drew L, Petrylak DP, Cassai NJS, Broudt-Rauf P, Fine RL (2006) J Biol Chem, in press.
38. Su ZZ, Madireddi MT, Lin JJ, Young CS, Kitada S, Reed JC, Goldstein NI, Fisher PB (1998) Proc Natl Acad Sci USA 95:14400-14405.
39. Mueller K, Ziereis K (1992) Arch Pharm (Weinheim) 325:219-223.
40. Turro NJ, Chow MF (1981) J Am Chem Soc 103:7218-7224.
41. Turro NJ, Chow MF, Rigaudy J (1979) J Am Chem Soc 101:1300-1302.